Deng X, Yang Y, Gan L, Duan X, Wang X, Zhang J
Pharmaceutics. 2025; 17(2).
PMID: 40006524
PMC: 11859093.
DOI: 10.3390/pharmaceutics17020157.
Kosyreva A, Vishnyakova P, Tsvetkov I, Kiseleva V, Dzhalilova D, Miroshnichenko E
Heliyon. 2023; 9(11):e21880.
PMID: 38027880
PMC: 10658332.
DOI: 10.1016/j.heliyon.2023.e21880.
Yan X, Sha X
Pharmaceutics. 2023; 15(10).
PMID: 37896217
PMC: 10610050.
DOI: 10.3390/pharmaceutics15102457.
Kandil R, Baldassi D, Bohlen S, Muller J, Jurgens D, Bargmann T
J Control Release. 2023; 354:305-315.
PMID: 36634709
PMC: 7614985.
DOI: 10.1016/j.jconrel.2023.01.014.
Baldassi D, Ngo T, Merkel O
Pharm Res. 2022; 41(1):77-91.
PMID: 36447020
PMC: 9708138.
DOI: 10.1007/s11095-022-03443-3.
A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants.
Rabaan A, Mutair A, Hajissa K, Alfaraj A, Al-Jishi J, Alhajri M
Vaccines (Basel). 2022; 10(10).
PMID: 36298520
PMC: 9611209.
DOI: 10.3390/vaccines10101655.
Pulmonary Delivery of Emerging Antibacterials for Bacterial Lung Infections Treatment.
Li J, Zheng H, Leung S
Pharm Res. 2022; 40(5):1057-1072.
PMID: 36123511
PMC: 9484715.
DOI: 10.1007/s11095-022-03379-8.
Nanoscale Porphyrin Metal-Organic Frameworks Deliver siRNA for Alleviating Early Pulmonary Fibrosis in Acute Lung Injury.
Weng C, Li G, Zhang D, Duan Z, Chen K, Zhang J
Front Bioeng Biotechnol. 2022; 10:939312.
PMID: 35923570
PMC: 9339993.
DOI: 10.3389/fbioe.2022.939312.
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes.
Baldassi D, Ambike S, Feuerherd M, Cheng C, Peeler D, Feldmann D
J Control Release. 2022; 345:661-674.
PMID: 35364120
PMC: 8963978.
DOI: 10.1016/j.jconrel.2022.03.051.
A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant.
Chang Y, Yang C, Chen Y, Yang C, Chou Y, Chou H
EMBO Mol Med. 2022; 14(4):e15298.
PMID: 35138028
PMC: 8988202.
DOI: 10.15252/emmm.202115298.
Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?.
Conte G, Costabile G, Baldassi D, Rondelli V, Bassi R, Colombo D
ACS Appl Mater Interfaces. 2022; 14(6):7565-7578.
PMID: 35107987
PMC: 8855343.
DOI: 10.1021/acsami.1c14975.
Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome.
Zoulikha M, Xiao Q, Boafo G, Sallam M, Chen Z, He W
Acta Pharm Sin B. 2021; 12(2):600-620.
PMID: 34401226
PMC: 8359643.
DOI: 10.1016/j.apsb.2021.08.009.
Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).
Seyfoori A, Shokrollahi Barough M, Mokarram P, Ahmadi M, Mehrbod P, Sheidary A
Int J Mol Sci. 2021; 22(13).
PMID: 34203268
PMC: 8269337.
DOI: 10.3390/ijms22136937.
Small interfering RNA: a tailored approach to explore the therapeutic potential in COVID-19.
Gatta A, Josyula V
Mol Ther Nucleic Acids. 2021; 23:640-642.
PMID: 33520405
PMC: 7826051.
DOI: 10.1016/j.omtn.2020.12.009.
